RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma

Seley Gharanei, Anna T. Brini, Sumathi Vaiyapuri, Abdullah Alholle, Ashraf Dallol, Elena Arrigoni, Takeshi Kishida, Toru Hiruma, Smadar Avigad, Robert Grimer, Eamonn R. Maher, Farida Latif

Research output: Contribution to journalArticle

Abstract

Ras-association domain family of genes consist of 10 members (RASSF1-RASSF10), all containing a Ras-association (RA) domain in either the C- or the N-terminus. Several members of this gene family are frequently methylated in common sporadic cancers; however, the role of the RASSF gene family in rare types of cancers, such as bone cancer, has remained largely uninvestigated. In this report, we investigated the methylation status of RASSF1A and RASSF2 in Ewing sarcoma (ES). Quantitative real-time methylation analysis (MethyLight) demonstrated that both genes were frequently methylated in Ewing sarcoma tumors (52.5% and 42.5%, respectively) as well as in ES cell lines and gene expression was upregulated in methylated cell lines after treatment with 5-aza-2′-deoxcytidine. Overexpression of either RASSF1A or RASSF2 reduced colony formation ability of ES cells. RASSF2 methylation correlated with poor overall survival (p = 0.028) and this association was more pronounced in patients under the age of 18 y (p = 0.002). These results suggest that both RASSF1A and RASSF2 are novel epigenetically inactivated tumor suppressor genes in Ewing sarcoma and RASSF2 methylation may have prognostic implications for ES patients.

Original languageEnglish
Pages (from-to)893-898
Number of pages6
JournalEpigenetics
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 2013

Fingerprint

Ewing's Sarcoma
Methylation
Genes
Cell Line
Bone Neoplasms
Aptitude
Tumor Suppressor Genes
Neoplasms
Gene Expression
Survival

Keywords

  • Ewing sarcoma
  • Methylation
  • RASSF1A
  • RASSF2
  • Survival

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Gharanei, S., Brini, A. T., Vaiyapuri, S., Alholle, A., Dallol, A., Arrigoni, E., ... Latif, F. (2013). RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. Epigenetics, 8(9), 893-898. https://doi.org/10.4161/epi.25617

RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. / Gharanei, Seley; Brini, Anna T.; Vaiyapuri, Sumathi; Alholle, Abdullah; Dallol, Ashraf; Arrigoni, Elena; Kishida, Takeshi; Hiruma, Toru; Avigad, Smadar; Grimer, Robert; Maher, Eamonn R.; Latif, Farida.

In: Epigenetics, Vol. 8, No. 9, 09.2013, p. 893-898.

Research output: Contribution to journalArticle

Gharanei, S, Brini, AT, Vaiyapuri, S, Alholle, A, Dallol, A, Arrigoni, E, Kishida, T, Hiruma, T, Avigad, S, Grimer, R, Maher, ER & Latif, F 2013, 'RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma', Epigenetics, vol. 8, no. 9, pp. 893-898. https://doi.org/10.4161/epi.25617
Gharanei, Seley ; Brini, Anna T. ; Vaiyapuri, Sumathi ; Alholle, Abdullah ; Dallol, Ashraf ; Arrigoni, Elena ; Kishida, Takeshi ; Hiruma, Toru ; Avigad, Smadar ; Grimer, Robert ; Maher, Eamonn R. ; Latif, Farida. / RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. In: Epigenetics. 2013 ; Vol. 8, No. 9. pp. 893-898.
@article{3c9d38cc2083416298eefb023560ccf4,
title = "RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma",
abstract = "Ras-association domain family of genes consist of 10 members (RASSF1-RASSF10), all containing a Ras-association (RA) domain in either the C- or the N-terminus. Several members of this gene family are frequently methylated in common sporadic cancers; however, the role of the RASSF gene family in rare types of cancers, such as bone cancer, has remained largely uninvestigated. In this report, we investigated the methylation status of RASSF1A and RASSF2 in Ewing sarcoma (ES). Quantitative real-time methylation analysis (MethyLight) demonstrated that both genes were frequently methylated in Ewing sarcoma tumors (52.5{\%} and 42.5{\%}, respectively) as well as in ES cell lines and gene expression was upregulated in methylated cell lines after treatment with 5-aza-2′-deoxcytidine. Overexpression of either RASSF1A or RASSF2 reduced colony formation ability of ES cells. RASSF2 methylation correlated with poor overall survival (p = 0.028) and this association was more pronounced in patients under the age of 18 y (p = 0.002). These results suggest that both RASSF1A and RASSF2 are novel epigenetically inactivated tumor suppressor genes in Ewing sarcoma and RASSF2 methylation may have prognostic implications for ES patients.",
keywords = "Ewing sarcoma, Methylation, RASSF1A, RASSF2, Survival",
author = "Seley Gharanei and Brini, {Anna T.} and Sumathi Vaiyapuri and Abdullah Alholle and Ashraf Dallol and Elena Arrigoni and Takeshi Kishida and Toru Hiruma and Smadar Avigad and Robert Grimer and Maher, {Eamonn R.} and Farida Latif",
year = "2013",
month = "9",
doi = "10.4161/epi.25617",
language = "English",
volume = "8",
pages = "893--898",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Taylor and Francis Inc.",
number = "9",

}

TY - JOUR

T1 - RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma

AU - Gharanei, Seley

AU - Brini, Anna T.

AU - Vaiyapuri, Sumathi

AU - Alholle, Abdullah

AU - Dallol, Ashraf

AU - Arrigoni, Elena

AU - Kishida, Takeshi

AU - Hiruma, Toru

AU - Avigad, Smadar

AU - Grimer, Robert

AU - Maher, Eamonn R.

AU - Latif, Farida

PY - 2013/9

Y1 - 2013/9

N2 - Ras-association domain family of genes consist of 10 members (RASSF1-RASSF10), all containing a Ras-association (RA) domain in either the C- or the N-terminus. Several members of this gene family are frequently methylated in common sporadic cancers; however, the role of the RASSF gene family in rare types of cancers, such as bone cancer, has remained largely uninvestigated. In this report, we investigated the methylation status of RASSF1A and RASSF2 in Ewing sarcoma (ES). Quantitative real-time methylation analysis (MethyLight) demonstrated that both genes were frequently methylated in Ewing sarcoma tumors (52.5% and 42.5%, respectively) as well as in ES cell lines and gene expression was upregulated in methylated cell lines after treatment with 5-aza-2′-deoxcytidine. Overexpression of either RASSF1A or RASSF2 reduced colony formation ability of ES cells. RASSF2 methylation correlated with poor overall survival (p = 0.028) and this association was more pronounced in patients under the age of 18 y (p = 0.002). These results suggest that both RASSF1A and RASSF2 are novel epigenetically inactivated tumor suppressor genes in Ewing sarcoma and RASSF2 methylation may have prognostic implications for ES patients.

AB - Ras-association domain family of genes consist of 10 members (RASSF1-RASSF10), all containing a Ras-association (RA) domain in either the C- or the N-terminus. Several members of this gene family are frequently methylated in common sporadic cancers; however, the role of the RASSF gene family in rare types of cancers, such as bone cancer, has remained largely uninvestigated. In this report, we investigated the methylation status of RASSF1A and RASSF2 in Ewing sarcoma (ES). Quantitative real-time methylation analysis (MethyLight) demonstrated that both genes were frequently methylated in Ewing sarcoma tumors (52.5% and 42.5%, respectively) as well as in ES cell lines and gene expression was upregulated in methylated cell lines after treatment with 5-aza-2′-deoxcytidine. Overexpression of either RASSF1A or RASSF2 reduced colony formation ability of ES cells. RASSF2 methylation correlated with poor overall survival (p = 0.028) and this association was more pronounced in patients under the age of 18 y (p = 0.002). These results suggest that both RASSF1A and RASSF2 are novel epigenetically inactivated tumor suppressor genes in Ewing sarcoma and RASSF2 methylation may have prognostic implications for ES patients.

KW - Ewing sarcoma

KW - Methylation

KW - RASSF1A

KW - RASSF2

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84883498462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883498462&partnerID=8YFLogxK

U2 - 10.4161/epi.25617

DO - 10.4161/epi.25617

M3 - Article

C2 - 23887284

AN - SCOPUS:84883498462

VL - 8

SP - 893

EP - 898

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

IS - 9

ER -